Ovation Diagnostics – Ovarian Cancer Detection
Ovation Diagnostics is dedicated to developing advanced and accessible ovarian cancer diagnostic technologies to address a global unmet need.
The Problem: Early Detection of Ovarian Cancer
- Ovarian cancer is the fifth leading cause of cancer induced death among women in the US
- Women currently affected with ovarian cancer
- In the US = 22,000
- In the world = 180,000
- Women currently affected with ovarian cancer
- Prognosis is poor; 5 year survival is no better than 37%
- Current tests fail to provide reliable screening at stage I of ovarian cancer
- About 60% of women are being diagnosed after the disease has spread beyond the ovary
The Solution: Ovation Diagnostics
- Early diagnosis is critical to reduce the risk of death from ovarian cancer
- Screening of ovarian cancer is necessary to identify early stages of ovarian cancer
- Using a urine dipstick instead of diagnosing through blood samples will make screening easier
- Levels of a protein marker called Bcl-2 are elevated in the urine of patients with ovarian cancer and are of diagnostic and/or prognostic clinical importance
- Prognosis is greater than 90% if identified in Stage 1
- Early diagnosis is critical to reduce the risk of death from ovarian
138 NW 16th Street | Boca Raton, FL 33432 | P: 561-705-0452 | F: 561-807-7302